Lipoprotein (a), low-density, intermediate-density lipoprotein, and blood pressure in a young male population

• Published in: The Clinical investigator Vol. 71; no. 2; p. 145
• Main Authors: Steinmetz, A, Kirklies, A, Schlosser, G, Cassel, W, Peter, J H, Ehlenz, K, Schäfer, J R, Wichert, P V, Kaffarnik, H
• Format: Journal Article
• Language: English
• Published: Germany 01.02.1993
• Subjects: Adult; Blood Pressure; Body Weight; Cholesterol - blood; Cohort Studies; Humans; Lipoprotein(a) - blood; Lipoproteins - blood; Lipoproteins, IDL; Lipoproteins, LDL - blood; Male; Middle Aged; Reference Values; Triglycerides - blood
• ISSN: 0941-0198
• DOI: 10.1007/BF00179996

Both hypercholesterolemia and hypertension are risk factors for atherosclerotic vascular disease, and elevated cholesterol levels occur more frequently than expected in patients with hypertension. Elevated levels of intermediate-density lipoproteins (IDL) and low-density lipoproteins (LDL) were shown to be atherogenic, and LDL, comprising the major cholesterol-carrying fraction in human plasma, are structurally related to lipoprotein (a)[Lp(a)], a further risk factor for atherosclerosis. In the present study we investigated 200 male employees (mean age 26 +/- 7 years) to determine whether the relationship of IDL and Lp(a) to systemic blood pressure is similar to the reported correlations between total and LDL cholesterol and systemic blood pressure. To this end blood pressure was measured several times in each individual, and lipids, lipoprotein-cholesterol, apolipoprotein B (apo B), and Lp(a) were determined in fasting serum. IDL cholesterol and apo B, the main protein component of IDL and LDL correlated with blood pressure. However, levels of Lp(a) correlated neither with systolic or diastolic blood pressure nor with lipoprotein cholesterol, body weight, or age. Although IDL and Lp(a) are considered lipoprotein risk factors for atherosclerosis, levels of Lp(a), unlike IDL, are not related to blood pressure, body weight, or age. Our data suggest different metabolic and pathophysiological mechanisms of the risk factors, IDL, LDL, and Lp(a).